<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209609</url>
  </required_header>
  <id_info>
    <org_study_id>CD0131</org_study_id>
    <nct_id>NCT03209609</nct_id>
  </id_info>
  <brief_title>VEST Venous Graft External Support Pivotal Study</brief_title>
  <acronym>VEST Pivotal</acronym>
  <official_title>A Multi-center, Randomized, Within-subject-controlled, Open Label Study of the Safety and Effectiveness of VEST, Venous External Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascular Graft Solutions Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Center for Health Outcomes and Innovation Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vascular Graft Solutions Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, randomized, within-subject-controlled , trial, enrolling patients
      with multi vessel atherosclerotic coronary artery disease, scheduled to undergo SVG CABG with
      arterial grafting of IMA to LAD and two or more saphenous vein grafts. In each patient, one
      SVG bypass will be randomized to be supported by the VEST, while another will not be
      supported and serve as control. Thus, the full cohort will provide a basis for comparison
      between two sets of SVGs: A VEST supported set; and an unsupported set.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical significance:

      Coronary artery bypass grafting (CABG) remains the gold standard treatment for patients with
      multi-vessel coronary artery disease. Despite the proposed benefits of multiple arterial
      grafts, autologous saphenous vein grafts (SVGs) are still the most frequently used bypass
      conduits in CABG. Progressive SVG failure after CABG remains a key limitation to the
      long-term success of surgery.

      Objective:

      Coronary artery bypass grafting (CABG) remains the gold standard treatment for patients with
      multi-vessel coronary artery disease. Despite the proposed benefits of multiple arterial
      grafts, autologous saphenous vein grafts (SVGs) are still the most frequently used bypass
      conduits in CABG. Progressive SVG failure after CABG remains a key limitation to the
      long-term success of surgery.

      Study design:

      Prospective, multi-center, randomized, within-subject-controlled , trial, enrolling patients
      with multi vessel atherosclerotic coronary artery disease, scheduled to undergo SVG CABG with
      arterial grafting of IMA to LAD and two or more saphenous vein grafts. In each patient, one
      SVG bypass will be randomized to be supported by the VEST, while another will not be
      supported and serve as control. Thus, the full cohort will provide a basis for comparison
      between two sets of SVGs: A VEST supported set; and an unsupported set.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 9, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>In each patient, one SVG bypass will be randomized to be supported by the VEST, while another will not be supported and serve as control.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intimal hyperplasia area/graft occlusion</measure>
    <time_frame>1 year</time_frame>
    <description>Intimal hyperplasia (plaque+media) area [mm2] as assessed by IVUS at 12 months. Occluded vessels are accounted for in the analysis of the primary endpoint</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lumen diameter uniformity</measure>
    <time_frame>1 year</time_frame>
    <description>Lumen diameter uniformity, assessed by angiography for each graft separately and expressed by the Fitzgibbon classification (22), on a 3-point ordinal scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vein graft failure</measure>
    <time_frame>1 year</time_frame>
    <description>Graft Failure (â‰¥50% stenosis) by cardiac angiography</description>
  </secondary_outcome>
  <other_outcome>
    <measure>MACCE</measure>
    <time_frame>annually over 5 years</time_frame>
    <description>Major adverse cardiac and cerebrovascular events</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">224</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>VEST supported vein graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Coronary artery bypass vein graft supported with the VEST implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care vein grafts</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coronary artery bypass vein grafts</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VEST</intervention_name>
    <description>External support for vein grafts, cobalt chrome braid</description>
    <arm_group_label>VEST supported vein graft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary artery bypass vein grafts</intervention_name>
    <description>Bypass coronary arteries with autologous saphenous vein grafts</description>
    <arm_group_label>VEST supported vein graft</arm_group_label>
    <arm_group_label>Standard of care vein grafts</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent, inclusive of release of medical information, and Health
             Insurance Portability and Accountability Act (HIPAA) documentation.

          2. Age 21 years or older.

          3. Planned and scheduled on-pump CABG.

          4. Two or more vein grafts: 1 for the right coronary artery, 1 or more for the left
             coronary arteries, with native vessels having at least 75% stenosis.

          5. IMA graft indicated for the LAD and additional arterial graft considered based on
             practice guidelines. A patient who is candidate for one, two, or more arterial grafts
             would only be eligible if in addition to the arterial grafts at least two vein grafts
             are used as specified above.

          6. Appropriately sized and accessible target coronary arteries, with a minimum diameter
             of 1.5 mm and adequate vascular bed (without significant distal stenosis), as assessed
             by pre-operative cardiac angiography.

        Exclusion Criteria:

          1. Concomitant non-CABG cardiac surgical procedure.

          2. Prior cardiac surgery.

          3. Emergency CABG surgery (cardiogenic shock, inotropic pressure support, IABP).

          4. Contraindication for on-pump CABG with cardioplegic arrest (e.g., severely calcified
             aorta).

          5. Calcification at the intended anastomotic sites, as assessed upon opening of the chest
             and before randomization.

          6. Severe vein varicosity as assessed after vein harvesting and before randomization.

          7. History of clinical stroke within 3 months prior to randomization.

          8. Severe renal dysfunction (Cr&gt;2.0 mg/dL).

          9. Documented or suspected untreated diffuse peripheral vascular disease such as: carotid
             stenosis or claudication of the extremities.

         10. Concomitant life-threatening disease likely to limit life expectancy to less than two
             years.

         11. Inability to tolerate or comply with required guideline-based post-operative drug
             regimen (antiplatelet plus statin) and/or inability to take aspirin.

         12. Inability to comply with required follow-ups including angiographic imaging methods
             (e.g. contrast allergy).

         13. Concurrent participation in an interventional (drug or device) trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Puskas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orit Yarden, PhD</last_name>
    <phone>+972 54 3073050</phone>
    <email>orit@graftsolutions.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kinjal Shah, PA-C</last_name>
    <phone>212-659-8399</phone>
    <email>kinjal.shah@mountsinai.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lutheran Hospital of Indiana</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Eichman, RN</last_name>
      <phone>260-458-3579</phone>
      <email>SEichman@Lutheran-Hosp.com</email>
    </contact>
    <investigator>
      <last_name>Joseph Ladowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Stokes, RN</last_name>
      <phone>603-650-6134</phone>
      <email>Henry.C.Stokes@hitchcock.org</email>
    </contact>
    <investigator>
      <last_name>Alexander Iribarne, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai St Luke's</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stella Palencia</last_name>
      <phone>212- 636-1873</phone>
      <email>Stella.Palencia@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>John D Puskas, MD, FACC, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital/Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyn Goldsmith, MA,RN,BSN</last_name>
      <phone>212-342-0261</phone>
      <email>lg2240@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Micahel Argenziano, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena Mamczur-Madry, RN, BSN, MS</last_name>
      <phone>718-920-3576</phone>
      <email>mmamczur@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Lou Mayer, RN, BSN</last_name>
      <phone>215-662-7981</phone>
      <email>Marylou.mayer@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Michael A Acker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Research Institute, The Heart Hospital Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heath Shirkey, RN, BSN, CCRP</last_name>
      <phone>469-814-4185</phone>
      <email>Heath.Shirkey@BSWHealth.org</email>
    </contact>
    <investigator>
      <last_name>Michael DiMaio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>March 11, 2018</last_update_submitted>
  <last_update_submitted_qc>March 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

